{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:31:07Z","timestamp":1787653867943,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This work was undertaken at the request of and sponsored by GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>GMMA are exosomes released from engineered Gram-negative bacteria resembling the composition of outer membranes. We applied the GMMA technology for the development of an O-Antigen (OAg) based vaccine against <jats:italic>Shigella sonnei<\/jats:italic>, the most epidemiologically relevant cause of shigellosis. <jats:italic>S. sonnei<\/jats:italic> OAg has been identified as a key antigen for protective immunity, and GMMA are able to induce anti-OAg-specific IgG response in animal models and healthy adults. The contribution of protein-specific antibodies induced upon vaccination with GMMA has never been fully elucidated. Anti-protein antibodies are induced in mice upon immunization with either OAg-negative and OAg-positive GMMA. Here we demonstrated that OAg chains shield the bacteria from anti-protein antibody binding and therefore anti-OAg antibodies were the main drivers of bactericidal activity against OAg-positive bacteria. Interestingly, antibodies that are not targeting the OAg are functional against OAg-negative bacteria. The immunodominant protein antigens were identified by proteomic analysis. Our study confirms a critical role of the OAg on the immune response induced by <jats:italic>S. sonnei<\/jats:italic> GMMA. However, little is known about OAg length and density regulation during infection and, therefore, protein exposure. Hence, the presence of protein antigens on <jats:italic>S. sonnei<\/jats:italic> GMMA represents an added value for GMMA vaccines compared to other OAg-based formulations.<\/jats:p>","DOI":"10.1038\/s41598-020-80421-y","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T11:26:43Z","timestamp":1610537203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA)"],"prefix":"10.1038","volume":"11","author":[{"given":"Francesca","family":"Mancini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Gasperini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Aruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Michelina","family":"Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Alfini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Necchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Micoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"80421_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/QCO.0000000000000475","volume":"31","author":"S Baker","year":"2018","unstructured":"Baker, S. & The, H. C. Recent insights into Shigella. Curr. Opin. Infect. Dis. 31, 449\u2013454. https:\/\/doi.org\/10.1097\/QCO.0000000000000475 (2018).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"80421_CR2","doi-asserted-by":"publisher","first-page":"e0003708","DOI":"10.1371\/journal.pntd.0003708","volume":"9","author":"CN Thompson","year":"2015","unstructured":"Thompson, C. N., Duy, P. T. & Baker, S. The rising dominance of Shigella sonnei: An intercontinental shift in the etiology of bacillary dysentery. PLoS Negl. Trop. Dis. 9, e0003708\u2013e0003708. https:\/\/doi.org\/10.1371\/journal.pntd.0003708 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"80421_CR3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/S1473-3099(18)30475-4","volume":"18","author":"IA Khalil","year":"2018","unstructured":"Khalil, I. A. et al. Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: The Global Burden of Disease Study 1990\u20132016. Lancet Infect. Dis. 18, 1229\u20131240. https:\/\/doi.org\/10.1016\/S1473-3099(18)30475-4 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"80421_CR4","volume-title":"Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics","author":"WHOrganization","year":"2017","unstructured":"WHOrganization. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics (WHO, Geneva, 2017)."},{"key":"80421_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.090","author":"BK Giersing","year":"2017","unstructured":"Giersing, B. K. et al. Report from the World Health Organization\u2019s third product development for vaccines advisory committee (PDVAC) meeting, Geneva, 8\u201310th June 2016. Vaccine https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.090 (2017).","journal-title":"Vaccine"},{"key":"80421_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","volume":"349","author":"D Cohen","year":"1997","unstructured":"Cohen, D. et al. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet 349, 155\u2013159. https:\/\/doi.org\/10.1016\/S0140-6736(96)06255-1 (1997).","journal-title":"Lancet"},{"key":"80421_CR7","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.vaccine.2009.12.050","volume":"28","author":"JH Passwell","year":"2010","unstructured":"Passwell, J. H. et al. Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1\u20134-year-old Israeli children. Vaccine 28, 2231\u20132235. https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.050 (2010).","journal-title":"Vaccine"},{"key":"80421_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00583-17","author":"KR Turbyfill","year":"2018","unstructured":"Turbyfill, K. R., Clarkson, K. A., Vortherms, A. R., Oaks, E. V. & Kaminski, R. W. Assembly, biochemical characterization, immunogenicity, adjuvanticity, and efficacy of Shigella artificial invaplex. mSphere https:\/\/doi.org\/10.1128\/mSphere.00583-17 (2018).","journal-title":"mSphere"},{"key":"80421_CR9","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1080\/21645515.2019.1606972","volume":"15","author":"LA Barel","year":"2019","unstructured":"Barel, L. A. & Mulard, L. A. Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human. Hum. Vaccin. Immunother. 15, 1338\u20131356. https:\/\/doi.org\/10.1080\/21645515.2019.1606972 (2019).","journal-title":"Hum. Vaccin. Immunother."},{"key":"80421_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/21645515.2019.1640427","volume":"16","author":"E Ndungo","year":"2020","unstructured":"Ndungo, E. & Pasetti, M. F. Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella. Hum. Vaccin. Immunother. 16, 197\u2013205. https:\/\/doi.org\/10.1080\/21645515.2019.1640427 (2020).","journal-title":"Hum. Vaccin. Immunother."},{"key":"80421_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1128\/cvi.00224-16","volume":"23","author":"MS Riddle","year":"2016","unstructured":"Riddle, M. S. et al. Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella flexneri 2a administered to healthy adults: A single-blind, randomized phase I study. Clin. Vaccin. Immunol. 23, 908\u2013917. https:\/\/doi.org\/10.1128\/cvi.00224-16 (2016).","journal-title":"Clin. Vaccin. Immunol."},{"key":"80421_CR12","doi-asserted-by":"publisher","first-page":"24922","DOI":"10.1074\/jbc.M114.566570","volume":"289","author":"O Rossi","year":"2014","unstructured":"Rossi, O. et al. Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: Relative activation of TLR4 and TLR2 pathways in different mutants. J. Biol. Chem. 289, 24922\u201324935. https:\/\/doi.org\/10.1074\/jbc.M114.566570 (2014).","journal-title":"J. Biol. Chem."},{"key":"80421_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1128\/CVI.00023-16","volume":"23","author":"O Rossi","year":"2016","unstructured":"Rossi, O. et al. Toll-like receptor activation by generalized modules for membrane antigens from lipid A mutants of Salmonella entericaSerovars Typhimurium and Enteritidis. Clin. Vaccine Immunol. 23, 304\u2013314. https:\/\/doi.org\/10.1128\/CVI.00023-16 (2016).","journal-title":"Clin. Vaccine Immunol."},{"key":"80421_CR14","doi-asserted-by":"publisher","first-page":"e0134478","DOI":"10.1371\/journal.pone.0134478","volume":"10","author":"C Gerke","year":"2015","unstructured":"Gerke, C. et al. Production of a Shigella sonnei vaccine based on generalized modules for membrane antigens (GMMA), 1790GAHB. PLoS ONE 10, e0134478\u2013e0134478. https:\/\/doi.org\/10.1371\/journal.pone.0134478 (2015).","journal-title":"PLoS ONE"},{"key":"80421_CR15","doi-asserted-by":"publisher","first-page":"e35616","DOI":"10.1371\/journal.pone.0035616","volume":"7","author":"F Berlanda Scorza","year":"2012","unstructured":"Berlanda Scorza, F. et al. High yield production process for Shigella outer membrane particles. PLoS ONE 7, e35616\u2013e35616. https:\/\/doi.org\/10.1371\/journal.pone.0035616 (2012).","journal-title":"PLoS ONE"},{"key":"80421_CR16","doi-asserted-by":"publisher","first-page":"e1800376","DOI":"10.1002\/biot.201800376","volume":"14","author":"Z Kis","year":"2019","unstructured":"Kis, Z., Shattock, R., Shah, N. & Kontoravdi, C. Emerging technologies for low-cost, rapid vaccine manufacture. Biotechnol. J. 14, e1800376\u2013e1800376. https:\/\/doi.org\/10.1002\/biot.201800376 (2019).","journal-title":"Biotechnol. J."},{"key":"80421_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ebiom.2017.07.013","volume":"22","author":"O Launay","year":"2017","unstructured":"Launay, O. et al. Safety profile and immunologic responses of a novel vaccine against Shigella sonnei administered intramuscularly, intradermally and intranasally: Results from two parallel randomized phase 1 clinical studies in healthy adult volunteers in Europe. EBioMedicine 22, 164\u2013172. https:\/\/doi.org\/10.1016\/j.ebiom.2017.07.013 (2017).","journal-title":"EBioMedicine"},{"key":"80421_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fimmu.2019.00335","volume":"10","author":"O Launay","year":"2019","unstructured":"Launay, O. et al. Booster vaccination with GVGH Shigella sonnei 1790GAHB gmma vaccine compared to single vaccination in unvaccinated healthy European adults: Results from a phase 1 clinical trial. Front. Immunol. 10, 335\u2013335. https:\/\/doi.org\/10.3389\/fimmu.2019.00335 (2019).","journal-title":"Front. Immunol."},{"key":"80421_CR19","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3389\/fimmu.2017.01884","volume":"8","author":"CW Obiero","year":"2017","unstructured":"Obiero, C. W. et al. A Phase 2a randomized study to evaluate the safety and immunogenicity of the 1790GAHB generalized modules for membrane antigen vaccine against Shigella sonnei administered intramuscularly to adults from a Shigellosis-Endemic Country. Front. Immunol. 8, 1884\u20131884. https:\/\/doi.org\/10.3389\/fimmu.2017.01884 (2017).","journal-title":"Front. Immunol."},{"key":"80421_CR20","doi-asserted-by":"publisher","first-page":"e1004749","DOI":"10.1371\/journal.ppat.1004749","volume":"11","author":"M Caboni","year":"2015","unstructured":"Caboni, M. et al. An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei. PLoS Pathog. 11, e1004749\u2013e1004749. https:\/\/doi.org\/10.1371\/journal.ppat.1004749 (2015).","journal-title":"PLoS Pathog."},{"key":"80421_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jim.2018.06.025","volume":"461","author":"F Necchi","year":"2018","unstructured":"Necchi, F., Saul, A. & Rondini, S. Setup of luminescence-based serum bactericidal assay against Salmonella Paratyphi A. J. Immunol. Methods 461, 117\u2013121. https:\/\/doi.org\/10.1016\/j.jim.2018.06.025 (2018).","journal-title":"J. Immunol. Methods"},{"key":"80421_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00661-14","author":"J-O Kim","year":"2015","unstructured":"Kim, J.-O. et al. Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection. Clin. Vaccin. Immunol. https:\/\/doi.org\/10.1128\/CVI.00661-14 (2015).","journal-title":"Clin. Vaccin. Immunol."},{"key":"80421_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.vaccine.2016.11.089","volume":"35","author":"G De Benedetto","year":"2017","unstructured":"De Benedetto, G. et al. Characterization of O-antigen delivered by generalized modules for membrane antigens (GMMA) vaccine candidates against nontyphoidal Salmonella. Vaccine 35, 419\u2013426. https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.089 (2017).","journal-title":"Vaccine"},{"key":"80421_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijmm.2015.12.003","volume":"306","author":"L Maggiore","year":"2016","unstructured":"Maggiore, L. et al. Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei generalized modules for membrane antigens (GMMA) reveals highly pure preparations. Int. J. Med. Microbiol. 306, 99\u2013108. https:\/\/doi.org\/10.1016\/j.ijmm.2015.12.003 (2016).","journal-title":"Int. J. Med. Microbiol."},{"key":"80421_CR25","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1128\/iai.00831-09","volume":"77","author":"Q Kong","year":"2009","unstructured":"Kong, Q., Liu, Q., Roland, K. L. & Curtiss, R. Regulated delayed expression of rfaH in an Attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen. Infect. Immun. 77, 5572\u20135582. https:\/\/doi.org\/10.1128\/iai.00831-09 (2009).","journal-title":"Infect. Immun."},{"key":"80421_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/CVI.00412-16","volume":"24","author":"AA Shimanovich","year":"2017","unstructured":"Shimanovich, A. A. et al. Functional and antigen-specific serum antibody levels as correlates of protection against shigellosis in a controlled human challenge study. Clin. Vaccin. Immunol. 24, 2. https:\/\/doi.org\/10.1128\/CVI.00412-16 (2017).","journal-title":"Clin. Vaccin. Immunol."},{"key":"80421_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.BAI-0023-2019","author":"P Schnupf","year":"2019","unstructured":"Schnupf, P. & Sansonetti, P. J. Shigella pathogenesis: New insights through advanced methodologies. Microbiol. Spect. https:\/\/doi.org\/10.1128\/microbiolspec.BAI-0023-2019 (2019).","journal-title":"Microbiol. Spect."},{"key":"80421_CR28","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1099\/mic.0.028944-0","volume":"155","author":"JA Carter","year":"2009","unstructured":"Carter, J. A. et al. The cellular level of O-antigen polymerase Wzy determines chain length regulation by WzzB and WzzpHS-2 in Shigella flexneri 2a. Microbiology 155, 3260\u20133269. https:\/\/doi.org\/10.1099\/mic.0.028944-0 (2009).","journal-title":"Microbiology"},{"key":"80421_CR29","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1126\/science.1108472","volume":"307","author":"NP West","year":"2005","unstructured":"West, N. P. et al. Optimization of virulence functions through glucosylation of Shigella LPS. Science 307, 1313\u20131317. https:\/\/doi.org\/10.1126\/science.1108472 (2005).","journal-title":"Science"},{"key":"80421_CR30","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1073\/pnas.120163297","volume":"97","author":"KA Datsenko","year":"2000","unstructured":"Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97, 6640\u20136645. https:\/\/doi.org\/10.1073\/pnas.120163297 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"80421_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carres.2013.12.003","volume":"385","author":"F Micoli","year":"2014","unstructured":"Micoli, F. et al. Structural analysis of O-polysaccharide chains extracted from different Salmonella typhimurium strains. Carbohyd. Res. 385, 1\u20138. https:\/\/doi.org\/10.1016\/j.carres.2013.12.003 (2014).","journal-title":"Carbohyd. Res."},{"key":"80421_CR32","doi-asserted-by":"publisher","first-page":"8282","DOI":"10.1021\/acsomega.7b01173","volume":"2","author":"G De Benedetto","year":"2017","unstructured":"De Benedetto, G., Cescutti, P., Giannelli, C., Rizzo, R. & Micoli, F. Multiple techniques for size determination of generalized modules for membrane antigens from Salmonella typhimurium and Salmonella enteritidis. ACS Omega 2, 8282\u20138289. https:\/\/doi.org\/10.1021\/acsomega.7b01173 (2017).","journal-title":"ACS Omega"},{"key":"80421_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ab.2012.10.038","volume":"434","author":"F Micoli","year":"2013","unstructured":"Micoli, F. et al. A scalable method for O-antigen purification applied to various Salmonella serovars. Anal. Biochem. 434, 136\u2013145. https:\/\/doi.org\/10.1016\/j.ab.2012.10.038 (2013).","journal-title":"Anal. Biochem."},{"key":"80421_CR34","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.vaccine.2014.01.011","volume":"32","author":"C Tani","year":"2014","unstructured":"Tani, C. et al. Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero(R) vaccine. Vaccine 32, 1273\u20131279. https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.011 (2014).","journal-title":"Vaccine"},{"key":"80421_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1074\/mcp.RA117.000045","volume":"17","author":"G Gasperini","year":"2018","unstructured":"Gasperini, G. et al. Outer membrane vesicles (OMV)-based and proteomics-driven antigen selection identifies novel factors contributing to bordetella pertussis adhesion to epithelial cells. Mol. Cell Proteomics 17, 205\u2013215. https:\/\/doi.org\/10.1074\/mcp.RA117.000045 (2018).","journal-title":"Mol. Cell Proteomics"},{"key":"80421_CR36","doi-asserted-by":"publisher","first-page":"e0172163","DOI":"10.1371\/journal.pone.0172163","volume":"12","author":"F Necchi","year":"2017","unstructured":"Necchi, F., Saul, A. & Rondini, S. Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout. PLoS ONE 12, e0172163\u2013e0172163. https:\/\/doi.org\/10.1371\/journal.pone.0172163 (2017).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80421-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80421-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80421-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T01:49:45Z","timestamp":1670032185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80421-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80421"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80421-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"1 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"906"}}